BACIL PHARMA
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Bacil Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
7.91₹ 2.93
As on Feb 9, 2026, 4:01 PM IST
Bacil Pharma Price Performance
Today's LowToday's High
₹35.06₹39.99
₹39.96
52 Weeks' Low52 Weeks' High
₹26.69₹47.90
₹39.96
Open Price
₹35.06
Prev. Close
₹37.03
Volume
781
Over the last 5 years, the share price of Bacil Pharma has gained 49.12% CAGR. Over the past year, the corresponding return has been -16.54%.
Bacil Pharma’s current P/E of 90.20x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Bacil Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Bacil Pharma | 0.65 | -6.00 | 41.90 | 6.56 | -16.54 | 79.32 | 49.12 |
| Sun Pharmaceutical Industries | 6.87 | -4.37 | 0.70 | 6.63 | -2.57 | 19.23 | 21.85 |
| Divi's Laboratories | 1.03 | -7.91 | -8.11 | -0.27 | -0.39 | 30.55 | 10.09 |
| Torrent Pharmaceuticals | 0.97 | -2.28 | 11.69 | 11.15 | 22.66 | 37.59 | 23.72 |
| Cipla | 1.40 | -8.51 | -10.77 | -9.99 | -8.82 | 9.19 | 9.63 |
| Dr. Reddy's Laboratories | 4.42 | 2.39 | 5.56 | 5.96 | 2.55 | 12.72 | 5.55 |
| Lupin | 2.76 | -0.14 | 12.12 | 13.57 | 0.50 | 43.25 | 15.62 |
| Zydus Lifesciences | 3.99 | -0.72 | -2.46 | -2.62 | -7.38 | 24.29 | 14.23 |
| Mankind Pharma | -1.81 | -9.74 | -7.81 | -17.92 | -17.15 | 13.58 | 7.94 |
| Aurobindo Pharma | -0.91 | -2.76 | 6.97 | 12.33 | 0.80 | 42.10 | 4.65 |
| Alkem Laboratories | 1.07 | -0.98 | 1.04 | 17.54 | 11.22 | 23.21 | 14.59 |
| Biocon | 2.01 | -3.43 | -1.64 | 2.55 | -3.23 | 16.30 | -1.78 |
| Abbott India | -0.81 | -3.66 | -4.69 | -16.22 | -7.87 | 9.41 | 13.62 |
| Glenmark Pharmaceuticals | -2.23 | -6.68 | 8.65 | -4.43 | 28.04 | 71.29 | 31.42 |
| Laurus Labs | 2.09 | -12.70 | 0.28 | 17.55 | 53.63 | 43.95 | 22.52 |
| GlaxoSmithKline Pharmaceuticals | 4.74 | 2.16 | -3.07 | -6.27 | 13.91 | 26.53 | 11.47 |
| Anthem Biosciences | 12.46 | 2.67 | -3.42 | -10.30 | -7.83 | -2.68 | -1.62 |
| Ipca Laboratories | -0.97 | -3.89 | 10.08 | 4.61 | -3.40 | 19.14 | 8.42 |
| Ajanta Pharma | 2.52 | 0.03 | 13.00 | 9.11 | 6.12 | 33.94 | 18.79 |
| Gland Pharma | 2.15 | 10.35 | 1.32 | -3.67 | 24.33 | 12.94 | -4.08 |
Over the last one year, Bacil Pharma has declined 16.54% compared to peers like Sun Pharmaceutical Industries (-2.57%), Divi's Laboratories (-0.39%), Torrent Pharmaceuticals (22.66%). From a 5 year perspective, Bacil Pharma has outperformed peers relative to Sun Pharmaceutical Industries (21.85%) and Divi's Laboratories (10.09%).
Bacil Pharma Financials
Bacil Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 38.72 | 38.45 |
| 10 | 39.26 | 39.32 |
| 20 | 41.09 | 39.9 |
| 50 | 39.6 | 39.5 |
| 100 | 38.74 | 39.3 |
| 200 | 41.63 | 38.22 |
Bacil Pharma Share Holding Pattern
In the latest quarter, Bacil Pharma remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 99.92% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Bacil Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Feb 06, 2026, 12:46 AM IST | Bacil Pharma - Board Meeting Intimation for We Wish To Inform You That The Meeting Of The Board Of Directors Of The Company I |
| Jan 14, 2026, 12:35 AM IST | Bacil Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Dec 20, 2025, 12:10 AM IST | Bacil Pharma - Appointment of Company Secretary and Compliance Officer |
| Dec 01, 2025, 11:56 PM IST | Bacil Pharma - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer |
| Nov 14, 2025, 1:10 AM IST | Bacil Pharma - Un-Audited Financial Result For 30Th September, 2025 |
About Bacil Pharma
Bacil Pharma Ltd. is a Public Limited Listed company incorporated on 08/05/1987 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24200MH1987PLC043427 and registration number is 043427. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 13.97 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressG2/G3, Samarpan Complex, Next To Mirador Hotel, Link Road, Mumbai Maharashtra 400099
- Contact
Management
- Ms. Chaitali Kalpataru ShahExecutive Director & CFO
- Mr. Dinesh Chander NotiyalIndependent Director
- Ms. Avani Savjibibhai GodhaniyaIndependent Director
FAQs on Bacil Pharma Share Price
What is the share price of Bacil Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Bacil Pharma is ₹39.96 as on Feb 09, 2026.
What kind of stock is Bacil Pharma?
The Bacil Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Bacil Pharma?
The market cap of Bacil Pharma is ₹57.35 Cr as on Feb 09, 2026.
What are today's High and Low prices of Bacil Pharma?
Today’s highest and lowest price of Bacil Pharma are ₹39.99 and ₹35.06.
What are the 52 Week High and 52 Week Low of Bacil Pharma?
The 52-week high/low is the highest and lowest price at which Bacil Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Bacil Pharma is ₹47.90 and 52-week low of Bacil Pharma is ₹26.69 as on Feb 09, 2026.
How has the Bacil Pharma performed historically in terms of returns?
The Bacil Pharma has shown returns of 7.91% over the past day, -6.0% for the past month, 41.9% over 3 months, -16.54% over 1 year, 79.32% across 3 years, and 49.12% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Bacil Pharma?
P/E ratio of and PB ratio of Bacil Pharma are 90.20 and 2.15 on Feb 09, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse